Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Stiff Man: A Case Study in Ankylosing Spondylitis

Charles Radis, DO  |  Issue: July 2017  |  July 12, 2017

At some point, Josh stopped coming to the office. He didn’t refill his prescriptions. We called his cell phone; no answer. I wondered if he’d moved or committed suicide, or overdosed. We never had been able to titrate the hydrocodone down. His burden of pain was real; between his end-stage knees and painful back, it seemed appropriate for Josh to be treated with narcotics. But I had my concerns. I checked the obituaries in the paper. Joanne finally tracked down Josh’s mother who was back living in northern Maine. I called her.

“Josh is in jail,” she said. “Dealing drugs. They got him, and now he’s in Thomaston.” There was a long pause. “I can only hope they give him a break. That boy has suffered enough.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I made a few calls. Through the prison system, Josh was getting a reasonable alternative to the intravenous infliximab, etanercept, which could be administered as an injection. I spoke to the doctor in charge, who reassured me that Josh was getting good care.

As the months and then years flowed by, I often thought of Josh and wondered if he’d ever had his knees replaced. I never did aspirate more fluid from a diseased knee. Josh’s aspirate of 300 cc remained a dubious record. At our weekly rheumatology conferences, Josh’s name would come up, as in, “This patient has very active disease, but not as severe as Josh N.’s ankylosing spondylitis.” The other rheumatologists would nod their heads and agree. No, Josh was the worst. The absolute worst. Whatever happened to him?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Then one day, Josh came in for an office visit. By now, he was in his mid-20s and had suffered with AS for 12 years. I watched as Joanne guided him down the hallway to the scale. Inside the exam room, he told me that his five years in prison was not altogether wasted. He’d gotten his GRE and learned a trade. A local vegetarian restaurant had recently hired him as a line cook. I watched Josh arrange himself in the exam chair—one pillow behind his back and the other under his butt. The T-shirt had been replaced by a loose-fitting, floral bowling shirt. My eyes scanned down to the front pocket: No cigarettes. Good. On his feet he wore bowling shoes with a Velcro strap closure. Very classy.

Pulling up a pant leg, he showed me the vertical scar of matching knee replacements. Beneath his shirt, he wore a soft Velcro back brace, which helped, he said, but most of the time he just put the pain aside and tried to stay busy.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic Conditions Tagged with:Ankylosing SpondylitisArthritisBack paincase reportClinicalDiagnosisManagementMedicationoffice visitpatient carerheumatologistrheumatologyspineTreatment

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences